Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.
Kidney International|November 2, 2025
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cellsBurcin Altun, Gexin Zhao, Baomei Wang, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioningRan Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Blood|April 16, 2026
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistenceJoseph S Durgin, Shin H Seo, Shadab Kazmi, et al.
Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Blood|April 1, 2014
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cellsJenny Zhang, Dereje Jima, Andrea B Moffitt, et al.
Leukemia & Lymphoma|June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma|March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemiaMolly E Graveno, Alison Carulli, Craig W Freyer, et al.
Pageof 12